General MedicationsTOPICALGeneric
OXYMETAZOLINE
OXYMETAZOLINE
Standard Dose
1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: None (Tentative Approval)
Summary
Approval overview OXYMETAZOLINE is listed in Drugs@FDA under application 211812 (ANDA).
Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient OXYMETAZOLINE Form and strength CREAM;TOPICAL - 1% Sponsor TEVA PHARMS USA INC Submission history Latest submission status date: 2022-10-28 00:00:00.
Structured Monograph
Clinical summary
Approval overview OXYMETAZOLINE is listed in Drugs@FDA under application 211812 (ANDA). Review priority: STANDARD Marketing status: None (Tentative Approval) Active ingredient OXYMETAZOLINE Form and strength CREAM;TOPICAL - 1% Sponsor TEVA PHARMS USA INC Submission history Latest submission status date: 2022-10-28 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: None (Tentative Approval)
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.